Idelalisib Tablet — FDA Drug Shortage

To Be Discontinued — Gilead Sciences, Inc.

The FDA lists a drug shortage record for Idelalisib Tablet (tablet) from Gilead Sciences, Inc. with status To Be Discontinued. The shortage was first posted on Apr 7, 2026.

Shortage details

Status
To Be Discontinued
Company
Gilead Sciences, Inc.
Package NDC
61958-1701-1
Dosage Form
Tablet
Presentation
Zydelig, Tablet, 100 mg (NDC 61958-1701-1)
Initial Posting
Apr 7, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.